Physician
Glover, Kelty & Schultheis MDS
Glover, Kelty & Schultheis MDS was paid $781K by Medicaid between Jan 2018 and Dec 2024, across 87 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 16% of everything it billed.
33Billing provider infoGLOVER, KELTY & SCHULTHEIS MDS
THOUSAND OAKS, CA 91360
THOUSAND OAKS, CA 91360
33aNPI1245263243assigned 07/10/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$781K
24GClaims323,196
24DCodes billed87
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#46 of 222
Median peer was paid$42K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 54,192 | $99K | |
| 2019 | 46,309 | $87K | |
| 2020 | 40,988 | $96K | |
| 2021 | 48,639 | $106K | |
| 2022 | 45,646 | $107K | |
| 2023 | 55,411 | $187K | |
| 2024incomplete | 32,011 | $100K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 16% | 1,595 | 1,570 | $124K |
| 80053 | Comprehensive metabolic panel | 13% | 51,447 | 27,625 | $103K |
| 85027 | 11% | 67,596 | 30,637 | $85K | |
| 83880 | 6.6% | 7,888 | 6,892 | $52K | |
| 83735 | 4.2% | 23,227 | 10,014 | $33K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.9% | 568 | 509 | $30K |
| 80048 | Basic metabolic panel (calcium, ionized) | 3.1% | 14,800 | 6,774 | $24K |
| 87040 | 3.0% | 6,435 | 5,178 | $23K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.9% | 464 | 433 | $23K |
| 84484 | 2.6% | 9,595 | 7,999 | $20K | |
| 87581 | 2.3% | 2,391 | 2,336 | $18K | |
| 87486 | 2.2% | 2,389 | 2,334 | $18K |
75 more codes
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.2% | 2,466 | $17K |
| 83690 | 2.0% | 11,451 | $16K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.9% | 527 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.9% | 3,630 | $15K |
| 83605 | 1.6% | 5,287 | $12K | |
| 86920 | 1.5% | 284 | $12K | |
| 81001 | 1.3% | 16,357 | $10K | |
| 85610 | 1.3% | 12,366 | $10K | |
| 84100 | 1.3% | 9,985 | $10K | |
| 87186 | 1.1% | 3,495 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,275 | $7K |
| 86140 | <1% | 6,062 | $6K | |
| 82150 | <1% | 4,598 | $6K | |
| 85730 | <1% | 4,470 | $6K | |
| 80061 | Lipid panel | <1% | 2,112 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,824 | $5K |
| 82803 | <1% | 1,466 | $5K | |
| 84703 | <1% | 3,176 | $4K | |
| 85379 | <1% | 2,078 | $4K | |
| 87070 | <1% | 2,339 | $4K | |
| 80202 | <1% | 1,383 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 66 | $4K |
| 82728 | <1% | 1,107 | $3K | |
| 86901 | <1% | 5,129 | $3K | |
| 86900 | <1% | 5,018 | $3K | |
| 86850 | <1% | 3,907 | $3K | |
| 82550 | <1% | 1,523 | $2K | |
| 80074 | <1% | 269 | $2K | |
| 80047 | <1% | 1,243 | $2K | |
| 84145 | <1% | 588 | $2K | |
| 87077 | <1% | 983 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 177 | $2K |
| 84439 | <1% | 901 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 763 | $2K |
| 83540 | <1% | 958 | $1K | |
| 87430 | <1% | 692 | $1K | |
| 80076 | <1% | 858 | $1K | |
| 84702 | <1% | 369 | $1K | |
| 82248 | <1% | 1,181 | $1K | |
| 82746 | <1% | 358 | $1K | |
| 82553 | <1% | 384 | $970.17 | |
| 85652 | <1% | 1,722 | $933.76 | |
| 85651 | <1% | 1,669 | $847.51 | |
| 87081 | <1% | 564 | $829.65 | |
| 84134 | <1% | 243 | $805.57 | |
| 83615 | <1% | 547 | $646.84 | |
| 85520 | <1% | 101 | $371.21 | |
| 88304 | <1% | 14 | $359.78 | |
| 87205 | <1% | 432 | $319.65 | |
| 82140 | <1% | 87 | $268.22 | |
| 87252 | <1% | 45 | $229.37 | |
| 84300 | <1% | 226 | $228.29 | |
| 85384 | <1% | 112 | $217.66 | |
| 82652 | <1% | 28 | $185.33 | |
| 85007 | <1% | 206 | $127.96 | |
| 87449 | <1% | 45 | $94.39 | |
| 82010 | <1% | 57 | $93.67 | |
| 82570 | <1% | 77 | $86.96 | |
| 87075 | <1% | 33 | $83.32 | |
| 82607 | <1% | 26 | $68.72 | |
| 84550 | <1% | 84 | $67.33 | |
| 85018 | <1% | 114 | $62.36 | |
| 82077 | <1% | 17 | $48.00 | |
| 85014 | <1% | 74 | $45.88 | |
| 83520 | <1% | 19 | $45.47 | |
| 83930 | <1% | 16 | $42.40 | |
| 87147 | <1% | 13 | $40.65 | |
| 85576 | <1% | 12 | $37.16 | |
| 86880 | <1% | 16 | $35.02 | |
| 84466 | <1% | 13 | $33.00 | |
| 87340 | <1% | 14 | $25.08 | |
| 85390 | <1% | 12 | $17.66 | |
| 83935 | <1% | 13 | $17.03 | |
| 85347 | <1% | 12 | $11.42 | |
| 80320 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHULTHEIS, WAYNE (PATHOLOGIST/MANAGING PARTNER)
| Provider | Location | Paid |
|---|---|---|
| Thousand Oaks Pathology Associates INC | Thousand Oaks, CA | $5.04M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.